NTNX vs TMO · P/E 108, rev $2.54B vs P/E 24, rev $23.00B
Nutanix Inc (NTNX) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Nutanix Inc (NTNX) is a software - infrastructure company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported NTNX revenue for 2025-07-31 was $2.54B. Net income was $188.4M. Revenue was up 18.1% from 2024-07-31 to 2025-07-31. NTNX currently screens at market cap $18.74B and trailing P/E 107.6.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
NTNX currently screens at market cap $18.74B and trailing P/E 107.6. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the NTNX and TMO stock pages for the full models.
Not investment advice.